KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 85 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $627,433 | +7.0% | 65,154 | 0.0% | 0.00% | – |
| Q2 2023 | $586,386 | +16.8% | 65,154 | +2.0% | 0.00% | – |
| Q1 2023 | $501,995 | +17.7% | 63,867 | +1.2% | 0.00% | – |
| Q4 2022 | $426,664 | -53.4% | 63,116 | 0.0% | 0.00% | – |
| Q3 2022 | $916,000 | +48.0% | 63,116 | +0.3% | 0.00% | – |
| Q2 2022 | $619,000 | -28.2% | 62,899 | +7.7% | 0.00% | – |
| Q1 2022 | $862,000 | +13.4% | 58,415 | +1.7% | 0.00% | – |
| Q4 2021 | $760,000 | -16.5% | 57,415 | +10.2% | 0.00% | – |
| Q3 2021 | $910,000 | -21.1% | 52,098 | +8.2% | 0.00% | – |
| Q2 2021 | $1,154,000 | -4.2% | 48,161 | +2.7% | 0.00% | – |
| Q1 2021 | $1,205,000 | +88.9% | 46,897 | +39.6% | 0.00% | – |
| Q4 2020 | $638,000 | +63.2% | 33,587 | +8.4% | 0.00% | – |
| Q3 2020 | $391,000 | -0.5% | 30,990 | -4.4% | 0.00% | – |
| Q2 2020 | $393,000 | +71.6% | 32,421 | +8.7% | 0.00% | – |
| Q1 2020 | $229,000 | -57.0% | 29,829 | 0.0% | 0.00% | – |
| Q4 2019 | $532,000 | +67.8% | 29,829 | +9.3% | 0.00% | – |
| Q3 2019 | $317,000 | -47.6% | 27,293 | 0.0% | 0.00% | – |
| Q2 2019 | $605,000 | – | 27,293 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 719,937 | $6,697,459 | 5.56% |
| TCG Crossover Management, LLC | 3,395,495 | $22,953,546 | 4.05% |
| VR Adviser, LLC | 2,916,667 | $19,716,669 | 3.32% |
| TANG CAPITAL MANAGEMENT LLC | 3,196,446 | $21,607,975 | 3.14% |
| Prosight Management, LP | 621,667 | $4,202,469 | 2.29% |
| Opaleye Management Inc. | 923,200 | $6,240,832 | 2.17% |
| GREAT POINT PARTNERS LLC | 1,055,801 | $7,137,215 | 1.40% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $21,894,687 | 1.36% |
| DAFNA Capital Management LLC | 616,032 | $4,164,376 | 1.17% |
| Vivo Capital, LLC | 856,008 | $5,787 | 0.67% |